Company profilePharmaceutical#745 of 1,318 in Pakistan✓ No DRAP alerts

Valor Pharmaceutcals

Pharmaceutical company · 12 brands · 8 molecules

Ranked #8 of 58 companies in Skin Conditions

12 registered products 10 pharmaceutical brands 8 distinct molecules 0 DRAP alerts

Company overview

12
registered products
10
pharmaceutical brands
8
distinct molecules
4
therapeutic classes
0
DRAP alerts

Valor Pharmaceutcals is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 12 product registrations across 8 distinct molecules. Its portfolio is concentrated in Skin Conditions and Anti-Infectives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Valor

11 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Therapeutic classes

Skin Conditions · 8Anti-Infectives · 2Antifungal For Dermatological · 1All Other Therapeutic Products, Antidotes · 1

Conditions treated

Eczema/Psoriasis/Dermatitis · 4Fungal Infection · 2Auto Immune Disease · 2Scabies · 1Acne/Topical · 1Infection/Allergy · 1Hyperpigmentation · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO4 products · Rs 374.51 – Rs 1,700.4
Servaid12 products · Rs 69.48 – Rs 1,355.1
Median across source: Rs 571.38

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 135 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
CRYSTOLITE PHARMACEUTICALS holds 65 molecules not in this portfolio
AcyclovirAdapaleneAmlodipineAnastrazoleAnastrozoleAscorbic Acid
VALOR PHARMACEUTICALS holds 155 molecules not in this portfolio
000 I.UAcetylcysteineAcitretinAcyclovirAdapaleneAdaplene

Get the full profile for Valor

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.